Tanzania's Mloganzila Industrial Park to Begin Drug Production in May 2027

The construction of pharmaceutical factories at Tanzania's Mloganzila Industrial Park in Dar es Salaam is underway, with investors showing interest in the project. The National Task Force for Accelerating Investment in Medicines Manufacturing (PIAT) has expressed satisfaction with the progress made so far. The task force, led by Health Minister Mohamed Mchengerwa, recently visited the industrial park to assess the development.

According to Mchengerwa, the government has created a favorable investment environment in the pharmaceutical sector, encouraging investors to establish factories in the country. This move is expected to reduce Tanzania's reliance on imported medicines, increase the availability of medical supplies, and boost the economy through local production. Mchengerwa also assured investors that they have a guaranteed market for their products not only in Tanzania but also in the East African Community and the Southern African region.

Deputy Permanent Secretary of the Ministry of Health, Emmanuel Tayari, revealed that all plots in the Mloganzila Industrial Park have attracted investors who have submitted their project plans. One of the investors, the Hongyu company, is nearing completion of the construction of buildings that will house pharmaceutical factories. Tayari noted that Hongyu has significant experience in producing and exporting medical supplies to the European market, indicating the potential for Tanzania to become a hub for pharmaceutical production and distribution.

The Mloganzila Industrial Park, launched on May 8, 2026, covers an area of approximately 450 acres and aims to attract investment in the production of various medical products. The PIAT task force, comprising experts from the health, industry, and investment sectors, is responsible for coordinating and accelerating investment in pharmaceutical factories to reduce reliance on imported medicines and strengthen the healthcare sector.

Tayari expects the benefits of the investment to become apparent starting in May 2027, when production of around 60% of medical supplies is anticipated to commence. This development is expected to improve the availability of medical products within the country. The government's efforts to create a favorable investment climate and the involvement of experienced investors like Hongyu are seen as crucial to the success of the project.

The Mloganzila Industrial Park is located in the Ubungo district of Dar es Salaam, and its development is seen as a strategic move to boost Tanzania's pharmaceutical sector. The park is expected to create opportunities for local production of medical supplies, reducing the country's reliance on imports and improving the overall quality of healthcare services.

As the project nears its production phase, stakeholders are optimistic about its potential impact on Tanzania's healthcare sector. With the government's support and the involvement of experienced investors, the Mloganzila Industrial Park is poised to become a significant player in the production and distribution of pharmaceutical products in the region.

Key points

• Production of medical supplies at the Mloganzila Industrial Park is expected to commence in May 2027.